GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.7760
+0.0513 (7.08%)
At close: Aug 4, 2025, 4:00 PM
0.7591
-0.0169 (-2.18%)
After-hours: Aug 4, 2025, 7:57 PM EDT
Elevation Oncology Revenue
GeoVax Labs had revenue of $852.28K in the quarter ending June 30, 2025, with 183.45% growth. This brings the company's revenue in the last twelve months to $6.14M, up 1,943.07% year-over-year. In the year 2024, GeoVax Labs had annual revenue of $3.95M.
Revenue (ttm)
$6.14M
Revenue Growth
+1,943.07%
P/S Ratio
1.37
Revenue / Employee
$361,356
Employees
17
Market Cap
19.68M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.95M | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 81.53K | -303.98K | -78.85% |
Dec 31, 2021 | 385.50K | -1.44M | -78.86% |
Dec 31, 2020 | 1.82M | 647.76K | 55.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
GOVX News
- 7 days ago - GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 8 months ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 9 months ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 9 months ago - GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewsWire